2. What should I know before I use ALTUVIIIO?
Do not use if you have ever had an allergic reaction to ALTUVIIIO, efanesoctocog alfa
or other factor VIII replacement factors, or any of the ingredients listed at the
end of the CMI.
Talk to your doctor if you have any other medical conditions, take any other medicines,
or are pregnant or plan to become pregnant or are breastfeeding.
3. What if I am taking other medicines?
Some medicines may interfere with ALTUVIIIO and affect how it works.
4. How do I use ALTUVIIIO?
Your doctor will decide what dose you will receive. Do not use more than the recommended
dose.
ALTUVIIIO is administered by slow injection directly into your vein.
ALTUVIIIO comes in a vial of sterile cake to powder and a pre-filled syringe containing
solvent. These need to be mixed before use.
5. What should I know while using ALTUVIIIO?
|
Things you should do
|
Tell your doctor immediately if bleeding is not controlled after using ALTUVIIIO.
Tell your doctor immediately if you become pregnant.
Tell any other doctors, dentist, or pharmacist you visit that you are using ALTUVIIIO.
Keep all your appointments with your doctor and any blood tests.
|
|
Things you should not do
|
Do not stop using this medicine or change the dose without checking with your doctor.
|
|
Looking after your medicine
|
Store in the refrigerator at 2°C to 8°C. Do not freeze.
Keep ALTUVIIIO in the pack until it is time to use it to protect from sunlight.
|
6. Are there any side effects?
Less serious side effects include pain in extremity, back pain, joint pain, fever,
headache, vomiting, itchy skin, red or dry skin, rash and reactions at the injection
site. A serious side effect is an allergic reaction with symptoms of swelling of the
face, rash, generalised itching, hives, tightness of the chest, difficulty breathing,
burning and stinging at the injection site, chills, flushing, headache, low blood
pressure, general feeling of being unwell, nausea, restlessness and fast heartbeat,
feeling dizzy and loss of consciousness.
This medicine is subject to additional monitoring. This will allow quick identification
of new safety information. You can help by reporting any side effects you may get.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems .
Active ingredient(s):
efanesoctocog alfa
Full Consumer Medicine Information (CMI)
This leaflet provides important information about using ALTUVIIIO. You should also speak to your doctor, Haemophilia Treatment Centre, or pharmacist
if you would like further information or if you have any concerns or questions about
using ALTUVIIIO.
Where to find information in this leaflet:
1. Why am I using ALTUVIIIO?
ALTUVIIIO contains the active ingredient efanesoctocog alfa. People with haemophilia
A lack sufficient factor VIII to control bleeding. ALTUVIIIO works by replacing factor
VIII to enable blood to clot.
ALTUVIIIO is used to:
routinely reduce the frequency of bleeding episodes,
control and prevent bleeding episodes,
reduce bleeding before, during, and after surgery.
ALTUVIIIO does not contain von Willebrand factor. Therefore, it is not suitable for
use in Von Willebrand's disease.
2. What should I know before I use ALTUVIIIO?
Warnings
Do not use ALTUVIIIO if:
you have an allergy to ALTUVIIIO or other factor VIII replacement factors, or any
of the ingredients listed at the end of this leaflet.
Always check the ingredients to make sure you can use this medicine.
Check with your doctor if you:
take any medicines for any other condition
During treatment, you may be at risk of developing certain side effects. It is important
you understand these risks and how to monitor for them. See additional information
under Section
6. Are there any side effects?
Pregnancy and breastfeeding
There is no information on the use of ALTUVIIIO during pregnancy. Your doctor will
discuss the risks and benefits of using it if you are pregnant.
Talk to your doctor if you are breastfeeding or plan to breastfeed. It is not known
whether ALTUVIIIO passes into breast milk. Your doctor will discuss the risks and
benefits of using it if you are breast-feeding.
3. What if I am taking other medicines?
Tell your doctor, Haemophilia Treatment Centre, or pharmacist if you are taking any
other medicines, including any medicines, vitamins or supplements that you buy without
a prescription from your pharmacy, supermarket or health food shop.
Your doctor or Haemophilia Treatment Centre staff have more information on medicines
to be careful with or avoid while using this medicine.
4. How do I use ALTUVIIIO?
How much to use
Follow all directions given to you by your doctor carefully. They may differ from
the information contained in this leaflet.
Your doctor will decide what dose you will receive (in International Units or "IU").
This will depend on your weight and whether it is used for prevention or treatment
of bleeding.
Your doctor may change the dose during your treatment.
Do not stop using ALTUVIIIO or change the dosage, without checking with your doctor
unless you have an allergic reaction.
How to use it
ALTUVIIIO is administered by slow injection into your veins.
ALTUVIIIO is provided as a powder in a vial and a pre-filled syringe containing a
sterile solvent also known as a diluent. These need to be mixed before use.
Mix the ALTUVIIIO powder with the diluent provided only when you are ready to use
it. Do not shake ALTUVIIIO when mixing it. Shaking can damage this medicine.
If you mix the powder and solvent and are interrupted, you can keep the mixed product
for a maximum of 3 hours if you store it below 30°C and protect it from direct sunlight.
Do not put it in the freezer.
Always inspect ALTUVIIIO after it has been mixed and before use. It should be clear
to slightly rainbow-like (opalescent) and colourless. Do not inject if the solution is cloudy or contains visible particles.
Refer to the leaflet in the pack for step-by-step instructions on how to prepare and
inject ALTUVIIIO.
ALTUVIIIO is for single use in one patient only. Dispose of any unused solution, vials,
and needles in a sharps bin. See additional information under, Getting rid of any
unwanted medicine.
If you have any questions about how to use ALTUVIIIO, talk to your doctor, or Haemophilia
Treatment Centre staff, or telephone 1800 818 806 (In Australia).
If you forget to use ALTUVIIIO
If you miss your dose at the usual time, use your dose as soon as you remember and
resume your normal dosing schedule.
Do not use a double dose to make up for the dose you missed.
If you are not sure what to do, ask your doctor or Haemophilia Treatment Centre staff.
If you use too much ALTUVIIIO
If you think that you or anyone else may have used too much ALTUVIIIO or have been
given too much ALTUVIIIO, you may need urgent medical attention.
You should immediately:
contact your doctor, or
go to the Emergency Department at your nearest hospital, or
contact the Poisons Information Centre (phone: 13 11 26).
You should do this even if there are no signs of discomfort or poisoning.
5. What should I know while using ALTUVIIIO?
Things you should do
Tell your doctor immediately if:
your bleeding is not controlled after using ALTUVIIIO.
you become pregnant while on treatment with ALTUVIIIO.
Before you use or take any other medicine, talk to your doctor or Haemophilia Treatment
Centre staff.
If you are about to have any blood tests, tell your doctor that you are using ALTUVIIIO.
Keep all your appointments with your doctor so your progress can be checked and have
any blood tests your doctor requests.
Remind any doctor, dentist, or pharmacist you visit that you are using ALTUVIIIO.
Things you should not do
Do not use more than the recommended dose.
Do not give ALTUVIIIO to anyone else even if they have the same condition as you.
Do not use ALTUVIIIO to treat any other complaints unless a doctor tells you to.
Do not stop using ALTUVIIIO or change the dosage without checking with your doctor.
Driving or using machines
ALTUVIIIO has no or negligible influence on your ability to drive and use machines.
Looking after your medicine
Keep ALTUVIIIO in the pack until it is time to use it, protected from light.
Store in the refrigerator at 2°C to 8°C. Do not freeze ALTUVIIIO.
If necessary, you can keep ALTUVIIIO out of the refrigerator for a single 6-month
period. If out of the refrigerator, store the sealed carton in a cool, dry place below
30°C. Record the date ALTUVIIIO was removed from the refrigerator on the carton. Do
not use ALTUVIIIO that has been out of the refrigerator for more than 6 months.
Once reconstituted, you can keep ALTUVIIIO at room temperature (below 30°C) for up
to 3 hours. Protect the product from direct sunlight. Do not freeze.
Do not use ALTUVIIIO after the expiry date printed on the pack or if the packaging
is torn or shows signs of tampering. If it has expired or damaged, return it to your
Haemophilia Treatment Centre for disposal.
Follow the instructions in the carton on how to take care of your medicine properly.
Keep it where young children cannot reach it.
Getting rid of any unwanted medicine
Do not throw away any medicines via the wastewater or household waste. If your doctor
tells you to stop using this medicine or it is out of date, ask your Haemophilia Treatment
Centre what to do with any medicine that is left over.
6. Are there any side effects?
All medicines can have side effects. If you do experience any side effects, most of
them are minor and temporary. However, some side effects may need medical attention.
See the information below and, ask your doctor, Haemophilia Treatment Centre, or pharmacist
if you have any further questions about side effects.
Less serious side effects
|
Less serious side effects
|
What to do
|
|
General body:
Pain in extremity (arms, hands, legs or feet)
Back pain
Arthralgia (joint pain)
Fever
Nerves
Headache
Digestive system:
Vomiting
Skin:
Eczema (itchy, red or dry skin)
Rash
Urticaria (itchy skin)
Reactions at the injection site (including bruising and inflammation)
|
Speak to your doctor or nurse if you have any of these symptoms.
|
Serious side effects
Your body can make antibodies called “inhibitors” against factor VIII which may stop
ALTUVIIIO from working properly. You will be monitored carefully for the development
of these inhibitors.
Tell your doctor, Haemophilia Treatment Centre staff, or pharmacist if you notice
anything else that may be making you feel unwell.
Other side effects not listed here may occur in some people.
Reporting side effects
After you have received medical advice for any side effects you experience, you can
report side effects to the Therapeutic Goods Administration online at
www.tga.gov.au/reporting-problems . By reporting side effects, you can help provide more information on the safety of
this medicine
Always make sure you speak to your doctor, Haemophilia Treatment Centre staff or pharmacist
before you decide to stop taking any of your medicines.
7. Product details
What ALTUVIIIO contains
Powder in a vial
|
Active ingredient
(main ingredient)
|
efanesoctocog alfa
|
|
Other ingredients
(inactive ingredients)
|
sucrose
calcium chloride dihydrate
histidine
arginine hydrochloride
polysorbate 80
|
Solvent in a pre-filled syringe
|
Active ingredient
(main ingredient)
|
Not applicable
|
|
Other ingredients
(inactive ingredients)
|
water for injections
|
Do not take this medicine if you are allergic to any of these ingredients.
What ALTUVIIIO looks like
ALTUVIIIO consists of:
1 vial of sterile ALTUVIIIO white to off-white cake to powder
1 pre-filled syringe containing a clear and colourless solvent
1 sterile vial adapter for mixing the powder and solvent
ALTUVIIIO is available in the following strengths:
250 International Units (IU) - AUST R 492507
500 International Units (IU) - AUST R 492510
1000 International Units (IU) - AUST R 492505
2000 International Units (IU) - AUST R 492506
3000 International Units (IU) - AUST R 492508
4000 International Units (IU) - AUST R 492509
Who distributes ALTUVIIIO
ALTUVIIIO is supplied in Australia by:
sanofi-aventis australia pty ltd
International Tower 3, Level 23
300 Barangaroo Avenue
Sydney NSW 2000
Toll Free No: 1800 818 806
This leaflet was prepared in June 2026.
altuviiio-ccdsv5-cmiv1-24jun26